丁基东莨菪碱对[18F]FDG在胃肠道摄取的影响可忽略且存在区域差异
回顾性分析458例肺癌PET/CT患者,其中218例使用丁基东莨菪碱、240例未使用;丁基东莨菪碱仅显著降低食管/胃和小肠的SUVmean,结肠和直肠/肛门无差异,肝脏和唾液腺SUVmean降低,骨骼肌和血池无影响,主观评估肠道病变信心无差异,但用药组更常认为需进一步诊断;结论认为不能据此给出通用推荐。
要点
- 丁基东莨菪碱仅显著降低食管/胃和小肠的FDG SUVmean,结肠和直肠/肛门无差异。
- 肝脏和唾液腺SUVmean降低,骨骼肌和血池未受影响。
- 主观评估肠道病变信心无差异,但用药组更常认为需进一步诊断。
核心结论
- 丁基东莨菪碱仅降低部分胃肠道节段的FDG聚集,尽管效应显著但程度很小。
- 不能据此给出使用丁基东莨菪碱的通用推荐,针对特定问题可个体化考虑其使用。
研究设计与样本
- 回顾性分析458例因肺癌行PET/CT的患者,其中218例使用丁基东莨菪碱、240例未使用,两组特征可比。
主要发现
- 使用丁基东莨菪碱后食管/胃和小肠的SUVmean显著降低,结肠和直肠/肛门无差异。
- 肝脏和唾液腺SUVmean降低,骨骼肌和血池未受影响。
- 丁基东莨菪碱的效应在男性和65岁以下患者中尤为明显。
- 主观评估肠道病变信心无差异,但丁基东莨菪碱组更常认为需进一步诊断。
临床怎么用
- 作者认为不能从这些结果推导出使用丁基东莨菪碱的通用推荐,针对特定问题可个体化考虑其使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Butylscopolamine (or hyoscine butylbromide, trade name Buscopan®) is occasionally administered as a premedication to reduce non-specific FDG uptake in the gastrointestinal tract based on its antiperistaltic effect. To date, there are no consistent recommendations for its use. The aim of this study was to quantify the reduction in intestinal and non-intestinal uptake by butylscopolamine administration and to derive relevance for clinical evaluation. RESULTS: 458 patients (PET/CT for lung cancer) were retrospectively reviewed. 218 patients with butylscopolamine and 240 patients without butylscopolamine had comparable characteristics. While the SUVmean in the gullet/stomach and small intestine was significantly reduced with butylscopolamine, the colon and rectum/anus showed no difference. The liver and salivary glands showed a reduced SUVmean, while skeletal muscle and blood pool were unaffected. An effect of butylscopolamine was particularly evident in men and patients under 65 years of age. There was no difference in the perceived confidence in the assessment of intestinal findings in the subjective evaluation, although in the butylscopolamine group further diagnostics appeared advisable more frequently. CONCLUSIONS: Butylscopolamine reduces gastrointestinal FDG accumulation only in selected segments and, despite a significant effect, only to a small extent. A general recommendation for the use of butylscopolamine cannot be derived from these results, its use for specific issues could be considered individually.
引用
- Gühne F, Ndum F, Seifert P, et al. The effect of butylscopolamine on [18F]FDG uptake in the gastrointestinal tract is negligible and regionally variable. EJNMMI Res. 2023. PMID: 37340145. doi:10.1186/s13550-023-01012-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。